Citation Impact
Citing Papers
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: Assessment of an oral agent that stimulates erythropoietin production
2005 StandoutNobel
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Enalapril treatment of posttransplant erythrocytosis: efficacy independent of circulating erythropoietin levels
1995
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
2005 Standout
Erythropoiesis after withdrawal of enalapril in post-transplant erythrocytosis
1994
Angiotensin-converting enzyme inhibitor therapy in chronic hemodialysis patients: Any evidence of erythropoietin resistance?
1996
Variations of Human Adrenomedullin Gene and Its Relation to Cardiovascular Diseases
2003
Reduced maternal expression of adrenomedullin disrupts fertility, placentation, and fetal growth in mice
2006 StandoutNobel
Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline.
1996
Cardioprotective Effect of Adrenomedullin in Heart Failure
2003
Adrenomedullin Promotes Proliferation and Migration of Cultured Endothelial Cells
2003
Global burden of hypertension: analysis of worldwide data
2005 Standout
Class II HDACs mediate CaMK-dependent signaling to NRSF in ventricular myocytes
2006
CIRCULATING ANGIOTENSIN II LEVELS UNDER REPEATED ADMINISTRATION OF LISINOPRIL IN NORMAL SUBJECTS
1992
Comparison of intravenous adrenomedullin with atrial natriuretic peptide in patients with congestive heart failure
2000
Hypertension in the Very Elderly Trial (HYVET)
2001
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>
2003 Standout
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
2010 Standout
Endocrine Mechanisms of Blood Pressure Rhythms
1996
Molecular basis of human hypertension: Role of angiotensinogen
1992 Standout
Measurement of plasma brain natriuretic peptide level as a guide for cardiac overload
2001
Uric Acid and Cardiovascular Risk
2008 Standout
Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A–deficient mice
2001 StandoutNobel
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
Natural History of Duodenal Lesions in Japanese Patients With Familial Adenomatosis Coli (Gardner's Syndrome)
1989
Complementation of reduced survival, hypotension, and renal abnormalities in angiotensinogen-deficient mice by the human renin and human angiotensinogen genes.
1997 StandoutNobel
Adrenomedullin (ADM) in the human forearm vascular bed: effect of neutral endopeptidase inhibition and comparison with proadrenomedullin NH2‐terminal 20 peptide (PAMP)
2001
Effect of enalapril on haemoglobin and serum erythropoietin in patients with chronic nephropathy
1990
Effects of adrenomedullin on cultured rat cardiac myocytes and fibroblasts
1999
Role of the N-terminal Catalytic Domain of Angiotensin-converting Enzyme Investigated by Targeted Inactivation in Mice
2004 StandoutNobel
Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention1European Society of Cardiology, European Atherosclerosis Society, European Society of Hypertension, International Society of Behavioural Medicine, European Society of General Practice/Family Medicine, European Heart Network.1,2Published simultaneously in the European Heart Journal 1998;19:1434–1503 and the Journal of Hypertension (Summary only) 1998;16(10).2
1998
Staphylococcus aureusProsthetic Valve Endocarditis: Optimal Management and Risk Factors for Death
1998
Magnesium in disease
2012
The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice.
1997 StandoutNobel
Prevalence, awareness, treatment, and control of hypertension in Greece The Didima study
1999
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
2001 Standout
Glial and neuronal control of brain blood flow
2010 StandoutNature
Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic Fibrosis
1994 Standout
Cough and Angioneurotic Edema Associated with Angiotensin-Converting Enzyme Inhibitor Therapy
1992
Treatment of Hypertension in Patients 80 Years of Age or Older
2008 Standout
High prevalence of adenomatous polyps of the duodenal papilla in familial adenomatous polyposis
1989
The Impact of Cardiac Natriuretic Peptide Determination on the Diagnosis and Management of Heart Failure
2001
Calmodulin Suppresses Synaptotagmin-2 Transcription in Cortical Neurons*
2010 StandoutNobel
Hereditary Colorectal Cancer
2003 Standout
Myonecrosis After Revascularization Procedures
1998
Cystic fibrosis: molecular biology and therapeutic implications
1992 StandoutScience
Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
2014 Standout
Estrogen, natriuretic peptides and the renin–angiotensin system
1999
Effect of Angiotensin-Converting Enzyme Inhibitors on Response to Erythropoietin Therapy in Chronic Dialysis Patients
1998
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
1999 Standout
Homeostasis in Mice with Genetically Decreased Angiotensinogen Is Primarily by an Increased Number of Renin-producing Cells
1999 StandoutNobel
Improved electrocardiographic detection of echocardiographic left ventricular hypertrophy: results of a correlated data base approach
1995
BIOLOGICAL AND CLINICAL ROLES OF ADRENOMEDULLIN IN CIRCULATION CONTROL AND CARDIOVASCULAR DISEASES
1999
Effects on Blood Pressure of Reduced Dietary Sodium and the Dietary Approaches to Stop Hypertension (DASH) Diet
2001 Standout
Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035
2020
Why is Erythropoietin Made in the Kidney?
2003
How far should blood pressure be reduced in diabetic hypertensive patients?
1997
Ambulatory Blood Pressure Is Superior to Clinic Blood Pressure in Predicting Treatment-Induced Regression of Left Ventricular Hypertrophy
1997
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
A Serum Shock Induces Circadian Gene Expression in Mammalian Tissue Culture Cells
1998 Standout
Effect of magnesium supplementation on blood pressure: a meta-analysis
2012
Treatment of Infections Associated with Surgical Implants
2004 Standout
Have expert panel guidelines kept pace with new concepts in hypertension?
1995
Association between Multiple Cardiovascular Risk Factors and Atherosclerosis in Children and Young Adults
1998 Standout
Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene
1990 Nature
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure
2002 Standout
Lack of angiotensin II–facilitated erythropoiesis causes anemia in angiotensin-converting enzyme–deficient mice
2000 StandoutNobel
Hemodynamic, Renal, and Hormonal Effects of Adrenomedullin Infusion in Patients With Congestive Heart Failure
2000
Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary Syndromes
1998 Standout
Effects of alcohol and caloric restrictions on blood pressure and serum lipids in overweight men.
1992
A genetic model defines the importance of the atrial natriuretic peptide receptor (guanylyl cyclase-A) in the regulation of kidney function
2000
Functional Deletion Mutation of the 5′-Flanking Region of Type A Human Natriuretic Peptide Receptor Gene and Its Association With Essential Hypertension and Left Ventricular Hypertrophy in the Japanese
2000
Genetic Models of Human Vascular Disease
1995 StandoutNobel
Exercise and blood pressure
1997
Recommendations for Blood Pressure Measurement in Humans and Experimental Animals
2004 Standout
Gardner's syndrome associated with periampullary carcinoma, duodenal and gastric adenomatosis
1982
The J-curve phenomenon in stroke recurrence.
1993
Prediction of Coronary Heart Disease Using Risk Factor Categories
1998 Standout
Serum urate and the risk of major coronary heart disease events.
1997
Adrenomedullin gene expression differences in mice do not affect blood pressure but modulate hypertension-induced pathology in males
2007 StandoutNobel
Measurement and significance of circulating natriuretic peptides in cardiovascular disease
1998
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Relation of Serum Lipoprotein Levels and Systolic Blood Pressure to Early Atherosclerosis
1986
The Japanese Trial to Assess Optimal Systolic Blood Pressure in Elderly Hypertensive Patients (JATOS): Protocol, Patient Characteristics, and Blood Pressure during the First 12 Months
2005
By how much does dietary salt reduction lower blood pressure? III--Analysis of data from trials of salt reduction.
1991
The Gardner Syndrome
1984
Cerebral amyloid angiopathy. A critical review.
1987
Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional Adrenomedullin gene
2001 StandoutNobel
Cardiac hypertrophy and sudden death in mice with a genetically clamped renin transgene
2004 StandoutNobel
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2010 Standout
Potent and Long-Lasting Vasodilatory Effects of Adrenomedullin in Humans
1997
Prediction of Cardiac Structure and Function by Repeated Clinic and Ambulatory Blood Pressure
1997
Upper gastrointestinal neoplasia in familial polyposis
1987
Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum.
1990
Evidence that atriopeptin is not a physiological regulator of sodium excretion.
1990
Carotid Arterial Stiffness as a Predictor of Cardiovascular and All-Cause Mortality in End-Stage Renal Disease
1998
Role of Endogenous Adrenomedullin in the Regulation of Vascular Tone and Ischemic Renal Injury
2002
Mineralocorticoid Blockade Reduces Vascular Injury in Stroke-Prone Hypertensive Rats
1998
Antisense Inhibition of Hypertension in the Spontaneously Hypertensive Rat
1995
Cerebral circulatory responses to hypercapnia and hypoxia in the recovery period following complete and incomplete cerebral ischemia in the rat
1983
Characteristics of 9194 Patients With Left Ventricular Hypertrophy
1998
Vascular Actions of Calcitonin Gene-Related Peptide and Adrenomedullin
2004
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults
2013 Standout
Changes in Left Ventricular Anatomy and Function in Hypertension and Primary Aldosteronism
1996
The Cholinergic Hypothesis of Geriatric Memory Dysfunction
1982 StandoutScience
Adrenomedullin, a Multifunctional Regulatory Peptide*
2000
Effectiveness of Management Strategies for Renal Artery Stenosis: A Systematic Review
2006
Effects of Alcohol Reduction on Blood Pressure
2001
Genetic Decreases in Atrial Natriuretic Peptide and Salt-Sensitive Hypertension
1995 StandoutScienceNobel
Neurotransmitter and carbohydrate metabolism during aging and mild hypoxia
1981
Myocardial Ultrasonic Backscatter in Hypertension
2003
1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension
1999 Standout
The role of ACE inhibitors and angiotensin II receptor blockers in the response to epoetin
1999
Adrenomedullin: Potential in physiology and pathophysiology
2000
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
Recommendations for Blood Pressure Measurement in Humans and Experimental Animals
2005 Standout
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
2002 Standout
High Plasma Level ofN-Acetyl-Seryl-Aspartyl-Lysyl-Proline
1997
Molecular phenotyping for analyzing subtle genetic effects in mice: Application to an angiotensinogen gene titration
2002 StandoutNobel
Works of Teruo Omae being referenced
1993 Guidelines for the management of mild hypertension: MEMORANDUM from a World Health Organization/International Society of Hypertension meeting
1993
Circadian Variations of Urinary Dopamine, Norepinephrine, Epinephrine and Sodium in Normotensive and Hypertensive Subjects
1990
Chronic Effects of Central and Systemic Administration of Losartan on BloodPressure and Baroreceptor Reflex in Spontaneously Hypertensive Rats
1994
Office Blood Pressure Variability as a Predictor of Brain Infarction in Elderly Hypertensive Patients.
2000
Increased plasma levels of adrenomedullin in patients with heart failure
1995
Antihypertensive Therapy Reduces Increased Plasma Levels of Adrenomedullin and Brain Natriuretic Peptide Concomitant with Regression of Left Ventricular Hypertrophy in a Patient with Malignant Hypertension.
1996
Clinical Evaluation of Delapril in Japan
1991
Role of systolic blood pressure in determining prognosis of hemodialyzed patients
1995
Current Status of Antihypertensive Therapy for Elderly Patients in Japan.
1996
Left ventricular structural characteristics in unilateral renovascular hypertension and primary aldosteronism
1988
Effects of alcohol restriction on 24-hour ambulatory blood pressure in japanese men with hypertension
1998
Hemorrhagic and Ischemic Cerebrovascular Complications of Active Infective Endocarditis of Native Valve
1993
Prognosis and outcome of elderly hypertensives in a Japanese community: results from a long-term prospective study
1988
Duodenal Lesions in Familial Polyposis of the Colon
1977
1993 Guidelines for the Management of Mild Hypertension: Memorandum from a WHO/ISH Meeting.
1993
'Spectacular shrinking deficit'
1992
Effects of aging on cerebral metabolism following bilateral carotid ligation in male spontaneously hypertensive rats (SHR)
1979
Effects of Changes in Dietary Sodium Intake and Saline Infusion on Plasma Atrial Natriuretic Peptide in Hypertensive Patients
1987
Effects of Magnesium Supplementation in Hypertensive Patients
1998
Primary familial amyloidosis with vitreous opacities
1978
Relationship Between Left Ventricular Geometry and Natriuretic Peptide Levels in Essential Hypertension
1996
Purification and properties of deoxyribonuclease from human urine
1978
Factors influencing the serum uric acid level. A study based on a population survey in Hisayama town, Kyushu, Japan
1980
Prior Events Predict Cerebrovascular and Coronary Outcomes in the PROGRESS Trial
2006
Comparison of Changes in Cardiac Structure After Treatment in Secondary Hypertension
1996
Alterations in Cerebrospinal Fluid Angiotensin II by Sodium Intake in Patients with Essential Hypertension
1989
Worsening of Anemia Induced by Long-Term Use of Captopril in Hemodialysis Patients
1984
Cerebrospinal Fluid and Arterial Lactate, Pyruvate and Acid-Base Balance in Patients With Intracranial Hemorrhages
1975
Plasma Atrial Natriuretic Polypeptide and Polyuria during Paroxysmal Tachycardia in Wolff-Parkinson-White Syndrome Patients
1986
Tissue Edema and Arterial Lesions Produced by Pure Submaxillary Gland Renin of Mouse
1978
A Sensitive Method for Precise Measurement of Endogenous Angiotensins I, II&III in Human Plasma
1987
CLINICOPATHOLOGICAL STUDY OF THE HEART AND CORONARY ARTERIES OF AUTOPSIED CASES FROM THE COMMUNITY OF HISAYAMA DURING A 10-YEAR PERIOD
1985
Coronary atherosclerosis and antecedent risk factors: Pathologic and epidemiologic study in Hisayama, Japan
1985
An evaluation of gastric cancer screening program in Hisayana, Japan
1977
Stroke-prone spontaneously hypertensive rats as an experimental model of malignant hypertension
1980
Epidemiological Studies on Cerebrovascular Diseases in Hisayama, Kyushu Island, Japan
1964